SOFIE’s vision is to improve patient outcomes by developing and delivering molecular diagnostics and therapeutics (theranostics). With our robust radiopharmaceutical production and distribution network, mature contract manufacturing services, and now, high value theranostic intellectual property, we are poised to deliver on the promise of radiopharmaceuticals from start to clinic. www.sofie.com www.twitter.com/sofiebio www.instagram.com/sofiebio
Location: United States, California, Culver City
Employees: 201-500
Total raised: $27.4M
Founded date: 2008
Investors 1
| Date | Name | Website |
| - | Cycad Grou... | cycadvc.co... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 03.11.2020 | Series C | $27.4M | - |
Mentions in press and media 1
| Date | Title | Description | Source |
| 31.01.2024 | Trilantic North America Makes Strategic Growth Investment in... | Trilantic North America announced today that it has entered into a definitive agreement to make a su... | trilanticn... |